Victory Capital Management Inc Viking Therapeutics, Inc. Transaction History

Victory Capital Management Inc

$98.4 Billion
Q1 2024

A detailed history of Victory Capital Management Inc transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 191,959 shares of VKTX stock, worth $10.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

191,959

Previous 37,500 411.89%

Holding current value

$10.2 Million

Previous $697,000 2158.25%

% of portfolio

0.02%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$17.4 - $94.5 $2.69 Million - $14.6 Million	154,459 Added 411.89%	191,959 $15.7 Million
Q4 2023 Feb 05, 2024	BUY	$9.24 - $19.64 $28,172 - $59,882	3,049 Added 8.85%	37,500 $697,000
Q3 2023 Nov 06, 2023	SELL	$10.92 - $16.0 $8.57 Million - $12.6 Million	-784,661 Reduced 95.79%	34,451 $381,000
Q2 2023 Jul 27, 2023	BUY	$14.84 - $24.79 $8.22 Million - $13.7 Million	553,792 Added 208.73%	819,112 $13.3 Million
Q1 2023 May 02, 2023	BUY	$8.08 - $17.33 $2.14 Million - $4.6 Million	265,320 New	265,320 $4.42 Million

Q4 2021 Feb 07, 2022	SELL	$4.6 - $6.72 $46,938 - $68,570	-10,204 Closed	0 $0
Q3 2021 Nov 02, 2021	SELL	$5.58 - $7.04 $2,114 - $2,668	-379 Reduced 3.58%	10,204 $64,000
Q2 2021 Aug 03, 2021	SELL	$5.19 - $6.73 $449,412 - $582,764	-86,592 Reduced 89.11%	10,583 $63,000
Q1 2021 May 04, 2021	SELL	$5.74 - $9.67 $27,477 - $46,290	-4,787 Reduced 4.69%	97,175 $615,000
Q4 2020 Feb 01, 2021	SELL	$5.3 - $6.71 $31,715 - $40,152	-5,984 Reduced 5.54%	101,962 $574,000
Q3 2020 Nov 09, 2020	SELL	$5.73 - $8.11 $240,826 - $340,855	-42,029 Reduced 28.02%	107,946 $628,000
Q2 2020 Aug 07, 2020	SELL	$4.35 - $8.08 $2,222 - $4,128	-511 Reduced 0.34%	149,975 $1.08 Million
Q1 2020 May 04, 2020	SELL	$3.45 - $7.95 $40,751 - $93,905	-11,812 Reduced 7.28%	150,486 $704,000
Q4 2019 Feb 06, 2020	BUY	$6.38 - $8.73 $73,784 - $100,962	11,565 Added 7.67%	162,298 $1.3 Million
Q4 2019 Feb 04, 2020	SELL	$6.38 - $8.73 $50,701 - $69,377	-7,947 Reduced 5.01%	150,733 $947,000
Q3 2019 Nov 12, 2019	BUY	$6.55 - $8.6 $1 Million - $1.32 Million	153,057 Added 2721.98%	158,680 $1.09 Million
Q4 2018 Feb 05, 2019	SELL	$7.16 - $16.21 $7,668 - $17,360	-1,071 Reduced 16.0%	5,623 $43,000
Q3 2018 Nov 01, 2018	BUY	$9.7 - $19.65 $8,536 - $17,292	880 Added 15.14%	6,694 $117,000
Q2 2018 Aug 02, 2018	SELL	$3.88 - $12.74 $2.33 Million - $7.64 Million	-599,980 Reduced 99.04%	5,814 $55,000
Q1 2018 May 04, 2018	BUY	$4.11 - $6.93 $1.69 Million - $2.85 Million	410,864 Added 210.78%	605,794 $2.65 Million
Q4 2017 Feb 01, 2018	BUY	$1.74 - $4.34 $339,178 - $845,996	194,930	194,930 $791,000

Others Institutions Holding VKTX

# of Institutions

426

Shares Held

63.1M

Call Options Held

7.39M

Put Options Held

5.13M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $4.07B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Viking Therapeutics, Inc. Transaction History